May 5-6, 2015 – San Francisco, CA PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today announced that Judith Greciet, CEO of Onxeo, has been invited to participate to the 2015 Allicense Conference as a panelist for the session entitled “Eat or Be Eaten—The Specialty Pharma Survival Story”. As one of the active deal-making organizations during the last months, especially with the last year’s acquisition and merger of TopoTarget by BioAlliance Pharma, Onxeo is a particularly compelling story, and certainly unique among mid-size European-based biotechs. Judith Greciet will contribute as a player and a witness to this very timely topic, with the recent Onxeo’s story of increasing size and critical mass through a merger in order to emerge as new global playor in the orphan oncology drugs area. Allicense Conference brings together professionals from the Pharma, Biotech and Financial communities. It offers opportunities for exchange of information and debate, especially in dealmaking, licensing and business development areas. The conference takes place on May 5 and 6 (the session “Eat or Be Eaten—The Specialty Pharma Survival Story” is on the 6th at 2:15pm) at the Park Central Hotel in San Francisco. About Allicense The Allicense Conference is the leading event for dealmaking, licensing and business development professionals, and is hosted by Thomson Reuters, the leading provider of intelligence for the life sciences Business Development and Licensing market. About Onxeo Onxeo has the vision to become a global leader and pioneer in oncology, with a focus on orphan or rare cancers, through developing innovative therapeutic alternatives designed to “make the difference”. The Onxeo team is determined to develop innovative medicines that provide patients with hope and significantly improve their lives. Key orphan oncology products at the advanced development stage are: Livatag® (Doxorubicin Transdrug™): Phase III in hepatocellular carcinoma Validive® (Clonidine Lauriad®): Phase II in severe oral mucositis: Positive preliminary top-line results Beleodaq® (belinostat): registered in the US in peripheral T-cell lymphoma For more information, visit the website www.onxeo.com (http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3 A %2F%2Fwww.onxeo.com&esheet=51070312&newsitemid=0&lan=en -US&anchor=www.onxeo.com&index=1&md5=81c24d9b7d6921c36891494a0368168c) Disclaimer This communication expressly or implicitly contains certain forward-looking statements concerning Onxeo and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Onxeo to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Onxeo is providing this communication as of this date and does not undertake to update any forward -looking statements contained herein as a result of new information, future events or otherwise. For a discussion of risks and uncertainties which could cause actual results, financial condition, performance or achievements of Onxeo to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the 2013 Reference Document filed with the AMF on April 7, 2014, which is available on the AMF website (http://www.amf -france.org (http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww . amf-france.org&esheet=51070312&newsitemid=0&lan=en -US&anchor=http%3A%2F%2Fwww.amf -france.org&index=2&md5=e9641d17b79ed3afc0163871bed2657e)) or on the company’s website (www.onxeo.com (http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2F w ww.onxeo.com&esheet=51070312&newsitemid=0&lan=en -US&anchor=www.onxeo.com&index=3&md5=7b5debad1a52b796ec1abec1b35b972a)). Onxeo S.A. Judith Greciet, CEO j.greciet@onxeo.com or Nicolas Fellmann, CFO n.fellmann@onxeo.com +33 1 45 58 76 00 or Alize RP Caroline Carmagnol / Sophie Colin, +33 6 64 18 99 59 / +33 1 44 54 36 62 onxeo@alizerp.com
Onxeo S.A.: Judith Greciet, invited as guest speaker at
Top 10 Most Recent News Articles
Milwaukee County Contract Tests Wisconsin Labor Shift
A unanimous first contract in a Milwaukee County department is not the sort of headline that rattles a trading screen, but it can tell you plenty about where the ground is moving. Public safety workers in the county Facilities Department have ratified their first agreement with Teamsters Local 344, according to the union. The vote matters less for any disclosed economic...
Continue Reading
Atalanta Takes Formal Verification Into Critical Systems
A week of bewildering infrastructure failures is a nasty time to discover nobody can explain the machinery. That was the backdrop for Atalanta CEO and co-founder Anjana Rajan at the National Academies of Sciences, Engineering, and Medicine's Cyber Resilience Forum, which concluded November 20 after two days in Washington. Her central point deserves more attention than the...
Continue Reading
Clear Aligner Results Depend on Discipline, Not Hype
A Clear Tray Is Not a Magic Wand Transparent orthodontic trays sell a wonderfully tidy idea: straighten teeth without the metal-and-wire routine, take them out to eat, and carry on. Fair enough. But the useful message from Dr. Theresa Trapp is the part nobody should glide past: clear aligners are a treatment plan, not a cosmetic shortcut bought with good intentions....
Continue Reading
Classic Chevrolet Gives $1.145M to 13 Local Groups
A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...
Continue Reading
E-Rate Risk and Data Center Rules Demand Attention
America’s digital plumbing is getting squeezed at both ends: the public connections nobody notices until they fail, and the industrial-scale computing boom everybody suddenly wants built yesterday. Connected Nation’s two bonus podcast episodes from the Broadband Nation Expo in New Orleans put those pressures side by side, and it is a more useful pairing than it may...
Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification
Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...
Continue Reading
SEIA's Young Advisors Put Succession Plans to the Test
A $166 million average book is not a cute training-program statistic. It says SEIA’s advisors aged 30 to 39 are already carrying serious client responsibility, and that matters because the registered investment advisory business is headed into a succession crunch nobody can solve with a glossy recruiting brochure. You Cannot Hand Off Trust Like a Spare Key Clients may...
Continue Reading
Alabama Power's 2027 Cut Puts Data Centers to Work
Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....
Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now
A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...
Continue Reading
Travel Disruptions Reveal the Value of Human Support
Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...
Continue ReadingTop 5 Most Recently Viewed Articles
CEO of Cogent Communications to Showcase Company Updates
Cogent Communications' CEO Will Share Insights at Key Conferences Cogent Communications Holdings, Inc. (NASDAQ: CCOI), recognized as one of the world's premier Internet service providers, has exciting news to share. Dave Schaeffer, the Chief Executive Officer, is set to present at two significant upcoming conferences, demonstrating leadership in the connectivity space....
Continue Reading
AnteraCapital 365 Unmasked: The Truth Behind Fraudulent Claims
Understanding the Fraud of AnteraCapital 365 Be an informed investor – protect yourself against fraudulent schemes. The Canadian Investment Regulatory Organization (CIRO) has issued a warning regarding AnteraCapital 365. This fraudulent firm operates on multiple websites claiming to be associated with legitimate organizations, specifically, SIG North Trading, ULC. It is...
Continue Reading
Understanding the Liberty Broadband and Charter Merger Insights
Rowley Law PLLC Conducts Investigation into Liberty Broadband Recently, Rowley Law PLLC has announced an investigation related to proposed acquisition activities involving Liberty Broadband Corporation (NASDAQ: LBRDA). This scrutiny comes amid news that Charter Communications, Inc. (NASDAQ: CHTR) intends to acquire Liberty Broadband. This proposed merger is set to impact...
Continue Reading
C3.ai Investors Urged to Act Now for Class Action Lawsuit
C3.ai Investors Face Class Action Lawsuit The recent developments regarding C3.ai, Inc. (NYSE: AI) are significant for investors who have faced substantial losses. The former Attorney General of Louisiana, Charles C. Foti, Jr., alongside Kahn Swick & Foti, LLC, has reached out to stakeholders, reminding them of an impending deadline related to a class action lawsuit....
Continue Reading
JW Michaels Shares Insights on Salary Trends in Finance
Understanding Executive Compensation in Financial Services Every year, companies and organizations strive to understand the nuances of compensation within the financial sector. JW Michaels & Co. recently released its latest Financial Services Market Data Report, offering valuable insights into executive remuneration practices for top-tier positions. This comprehensive...
Continue Reading